We are live on
!
Find out more
HL
Harding Loevner Portfolio holdings
AUM
$9.72B
1-Year Est. Return
22.38%
This Fund
S&P 500
This Quarter
Est. Return
-1.92%
1 Year Est. Return
+22.38%
3 Year Est. Return
+79.36%
5 Year Est. Return
+98.01%
10 Year Est. Return
+375.62%
AUM
$15.3B
AUM Growth
-$956M
(-5.9%)
Cap. Flow
-$431M
Cap. Flow
% of AUM
-2.83%
Top 10 Holdings %
Top 10 Hldgs %
38.03%
Holding
163
New
10
Increased
23
Reduced
75
Closed
1
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$261M |
| 2 |
Manulife Financial
MFC
|
+$76.5M |
| 3 |
PayPal
PYPL
|
+$59.5M |
| 4 |
Salesforce
CRM
|
+$59.4M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$47M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$81.5M |
| 2 |
Grupo Aeroportuario del Sureste
ASR
|
+$62.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$60.9M |
| 4 |
EPAM Systems
EPAM
|
+$59.5M |
| 5 |
Diageo
DEO
|
+$52.8M |
Sector Composition
| 1 | Technology | 20.31% |
| 2 | Financials | 19.91% |
| 3 | Healthcare | 16.41% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Core Laboratories
CLB
$530M
| $1.66M | 0.01% |
123,222
+7,543
| +7% | +$127K |
|
77
iShares MSCI EAFE Growth ETF
EFG
$16.5B
| $1.43M | 0.01% |
+19,760
| New | +$1.61M |
|
78
Check Point Software Technologies
CHKP
$14.2B
| $880K | 0.01% |
7,853
-8,530
| -52% | -$1.03M |
|
79
iShares MSCI EAFE ETF
EFA
$76.9B
| $393K | ﹤0.01% |
7,011
-3,290
| -32% | -$205K |
|
|
80
Diageo
DEO
$47.5B
| $280K | ﹤0.01% |
1,646
-294,492
| -99% | -$52.8M |
|
81
ExxonMobil
XOM
$605B
| $171K | ﹤0.01% |
+1,955
| New | +$178K |
|
82
BioNTech
BNTX
$23.2B
| $162K | ﹤0.01% |
1,202
| – | – |
|
83
NetEase
NTES
$83.4B
| $115K | ﹤0.01% |
1,521
+97
| +7% | +$8.53K |
|
84
Banco Santander
SAN
$195B
| $114K | ﹤0.01% |
49,212
| – | – |
|
85
Vanguard Total World Stock ETF
VT
$77.2B
| $94K | ﹤0.01% |
1,190
-3,780
| -76% | -$332K |
|
86
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
| $86K | ﹤0.01% |
2,150
-998,553
| -100% | -$44.4M |
|
87
Gartner
IT
$9.57B
| $86K | ﹤0.01% |
311
| – | – |
|
88
AbbVie
ABBV
$449B
| $85K | ﹤0.01% |
637
| – | – |
|
89
Reinsurance Group of America
RGA
$15.7B
| $84K | ﹤0.01% |
671
| – | – |
|
90
Neurocrine Biosciences
NBIX
$17.2B
| $81K | ﹤0.01% |
767
-43
| -5% | -$4.36K |
|
91
BorgWarner
BWA
$12.9B
| $80K | ﹤0.01% |
2,890
| – | – |
|
92
Bristol-Myers Squibb
BMY
$124B
| $77K | ﹤0.01% |
1,086
| – | – |
|
|
SBNY
93
DELISTED
Signature Bank
SBNY
| $71K | ﹤0.01% |
471
+258
| +121% | +$46.9K |
|
94
Ryanair
RYAAY
$34.5B
| $67K | ﹤0.01% |
2,858
+1,430
| +100% | +$40.3K |
|
95
Merck
MRK
$315B
| $63K | ﹤0.01% |
734
| – | – |
|
96
JPMorgan Chase
JPM
$912B
| $62K | ﹤0.01% |
589
| – | – |
|
97
HEICO Corp
HEI
$48.1B
| $60K | ﹤0.01% |
419
| – | – |
|
98
Unilever
UL
$135B
| $50K | ﹤0.01% |
+1,020
| New | +$53.3K |
|
99
Starbucks
SBUX
$124B
| $49K | ﹤0.01% |
578
| – | – |
|
100
Teradyne
TER
$50.5B
| $46K | ﹤0.01% |
618
| – | – |
|
Similar funds
DCP
FCM
CCM
CIM
URS
MPI
TIM
DPIM